Villarin, Romeo .
HRN: 26-35-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/21/2024
12/27/2024
IV
500mg
Q6h
H Pylori Infection
Waiting Final Action
Indication: Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes